Related Experiment Videos
Industry comment on the 1995 revised Australian pharmacoeconomic guidelines
M P Grobler1, K Macarounas-Kirchmann, G A Pearce
1Australian Pharmaceutical Manufacturers Association, North Sydney, New South Wales, Australia.
Pharmacoeconomics
|March 8, 1996
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Mid-life social participation and physical performance at age 60-64: evidence from the 1946 British Birth Cohort Study.
European journal of public health·2019
Socioeconomic inequalities in resilience and vulnerability among older adults: a population-based birth cohort analysis.
International psychogeriatrics·2017
Operationalising resilience in longitudinal studies: a systematic review of methodological approaches.
Journal of epidemiology and community health·2016
Resilience measurement in later life: a systematic review and psychometric analysis.
Health and quality of life outcomes·2016
Operational Definition of Active and Healthy Ageing (AHA): A Conceptual Framework.
The journal of nutrition, health & aging·2015
Cost-Effectiveness and Budget Impact of Lung Cancer Screening: A Systematic Review.
PharmacoEconomics·2026
Comparing User-Written Codes for Performing Economic Evaluations in Stata.
PharmacoEconomics·2026
[Interpretation of the latest Sixth Conference of the Parties (COP-6) decision of the Minamata Convention on Mercury].
Zhonghua kou qiang yi xue za zhi = Zhonghua kouqiang yixue zazhi = Chinese journal of stomatology·2026
Financial risk protection and Nigeria's journey towards universal health coverage.
npj health systems·2026
Respiratory Syncytial Virus Suppression through Public Health and Social Measures, Hong Kong, China, 2020-2023.
Emerging infectious diseases·2026